Screener
Charles River Laboratories CRL EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Charles River Laboratories’s reported figures.
Based on trailing twelve months.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
FAQ
- What is Charles River Laboratories's EBITDA margin?
- Charles River Laboratories (CRL) reported EBITDA margin of 16.8% in Q2 2026.
- How has Charles River Laboratories's EBITDA margin changed year-over-year?
- Charles River Laboratories's EBITDA margin decreased by 12.7% year-over-year, from 19.2% to 16.8%.
- What is the long-term trend for Charles River Laboratories's EBITDA margin?
- Over 5 years (2020 to 2025), Charles River Laboratories's EBITDA margin has grown at a -5.0% compound annual growth rate (CAGR), from 22.8% to 17.7%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Charles River Laboratories's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude